Buy STEGLATRO 15 mg/1 ertugliflozin

STEGLATRO 15 mg is a medication containing ertugliflozin, used to manage type 2 diabetes. This oral tablet helps control blood sugar levels. Learn more about its uses and effects.

Strength

15 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0006-5364-03)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

STEGLATRO 15 mg is primarily used to manage type 2 diabetes. It works by helping the kidneys remove excess glucose from the body through urine. This medication is often part of a broader treatment plan that includes diet and exercise. People may wonder, 'What is STEGLATRO used for?' It is designed to improve glycemic control in adults with type 2 diabetes.

Side Effects

Common effects of STEGLATRO 15 mg may include increased urination, which helps remove excess glucose. Some users might experience symptoms like dehydration or low blood sugar. It's important to stay hydrated while taking this medication. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

STEGLATRO 15 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions. People with certain medical conditions, such as kidney problems, should discuss their health status with a healthcare provider before starting this medication. Always store the tablets in a cool, dry place.

Avoid Interactions

STEGLATRO 15 mg may interact with other medications, including diuretics and insulin. It's important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and overall health.

References

Frequently Asked Questions

STEGLATRO 15 mg is used to manage type 2 diabetes by helping the kidneys remove excess glucose through urine.

STEGLATRO 15 mg is taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include increased urination and symptoms of dehydration. Always consult a healthcare provider for personalized advice.

It is advisable to moderate alcohol consumption while taking STEGLATRO, as it can affect blood sugar levels and overall health.

STEGLATRO 15 mg can be purchased from licensed online pharmacies. Ensure you are buying from a reputable source.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.